Pharmalink Completes Enrolment of Patients into Phase IIB Clinical Study ... PR Newswire (press release) ... or kidney transplantation. IgA nephropathy accounts for 10% of renal transplants among patients with primary glomerulonephritis in the US and between 7-20% of patients in Europe and Australia in long-term dialysis and renal transplantation programs. |
